● Recruiting

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Condition: Pancreatic Ductal Adenocarcinoma · Non Small Cell Lung Cancer · Colorectal Cancer · Sponsor: Verastem, Inc.

PhasePhase 1/Phase 2

Planned participants295

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study will assess the safety and efficacy of VS-7375 alone and in combination in patients with advanced solid tumors harboring a KRAS G12D-mutation.

This description comes directly from the study's public registry record.

Talk to the study team

Verastem Call Center · 1 781 292 4204 · clinicaltrials@verastem.com

Always discuss trial participation with your own doctor first.

Locations (14)

Cedars-Sinai Medical Center	Los Angeles, California, United States	Recruiting
Johns Hopkins University	Baltimore, Maryland, United States	Recruiting
Massachusetts General Hospital	Boston, Massachusetts, United States	Recruiting
University of Michigan	Ann Arbor, Michigan, United States	Recruiting
Washington University School of Medicine	St Louis, Missouri, United States	Recruiting
Laura & Isaac Perlmutter Cancer Center at NYU Langone	New York, New York, United States	Recruiting
Univ of Pennsylvania, Abramson Cancer Center	Philadelphia, Pennsylvania, United States	Recruiting
SCRI Oncology Partners	Nashville, Tennessee, United States	Recruiting
MD Anderson Cancer Center	Houston, Texas, United States	Recruiting
Huntsman Cancer Institute	Salt Lake City, Utah, United States	Recruiting
University of Virginia	Charlottesville, Virginia, United States	Recruiting
Virginia Cancer Specialists	Fairfax, Virginia, United States	Recruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07020221